soul trial oral semaglutide cardiovascular outcomes 2024 nejm 2025 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Oral Semaglutide and Cardiovascular Outcomes
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13






.png?w=1280&max-h=720&fit=crop&auto=format)














